select semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design Long-Term SELECT Trial: Semaglutide Cuts
Description
That is why a simple traffic-light framework can help: Green Mild, expected, improving symptoms
26,32 Additionally, treatments are often associated with side effects and/or exhibit insufficient efficacy
95% CI, 0.04 to 3.23) did not significantly increase in the GLP-1 RA group compared with the DM control group
These medications mimic the glucagon-like peptide-1 (GLP-1) hormone, which naturally helps control appetite, slow digestion, and regulate insulin response
(n.d.) Research Spotlight: Type 1 diabetes staging classification opens door for intervention
